Cardiogenic shock after ST elevation myocardial infarction and IABP-SHOCK II risk score validation in a cohort treated with pharmacoinvasive strategy.
Pedro Ivo M MoraesClaudia Rodrigues AlvesMarco Tulio SouzaSuzi Emiko KawakamiIran GoncalvesAdriano Henrique Pereira BarbosaAntonio Celio MorenoAdriano Mendes CaixetaAntonio Carlos CarvalhoPublished in: Open heart (2019)
In patients with cardiogenic shock after STEMI treated with PhIS, risk stratification using IABP-SHOCK II score was adequate. There was no influence of pain-to-needle and fibrinolytic-catheterisation times on the ability to the score model stratification.